# Alzheimer's Disease Acitretin Medication

> **NCT01078168** · PHASE2 · COMPLETED · sponsor: **K. Lieb** · enrollment: 22 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Acitretin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01078168
- **Lead sponsor:** K. Lieb
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2013-01
- **Final completion:** 2013-05
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2018-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01078168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01078168, "Alzheimer's Disease Acitretin Medication". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01078168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*